Schedule 13G ownership disclosure

Arcus Biosciences Inc

Security class unavailable · CUSIP: 03969F109

Event date: 2021-07-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,572,047
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000427
Form type
SC 13G
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
Jul 19, 2021
Reporting period
Jul 09, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub